TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Table of Contents (Version-2026)

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Drug Type
• Market Snippet, By Disease Type
• Market Snippet, By Distribution Channel
• Market Snippet, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Clinical Characteristics
• Disease Diagnosis
• Treatment Overview
• Mechanism Of Action
• Pipeline Analysis
• Product Approval/Launches
• Partnership- Collaboration Scenario
• Epidemiology
• Pest Analysis
• Porter’s Five Forces Analysis
• Drivers
• Restraints
• Market Opportunities

4. Global Transthyretin Amyloidosis Treatment Market, By Drug Type, 2016–2026 (US$ Mn)

• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017–2026
• Segment Trends
• Tafamidis (Vyndaqel)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
• Patisiran (ONPATTRO)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
• Inotersen (TEGSEDI)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)

5. Global Transthyretin Amyloidosis Treatment Market, By Disease Type, 2016–2026 (US$ Mn)

• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017–2026
• Segment Trends
• Hereditary Transthyretin Amyloidosis
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
• Polyneuropathy
• Cardiomyopathy
• Mixed Type
• Wild Type Amyloidosis
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)

6. Global Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2016–2026 (US$ Mn)

• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017–2026
• Segment Trends
• Hospital Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
• Specialty Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
• Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
• Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)

7. Global Transthyretin Amyloidosis Treatment Market, By Geography, 2016 – 2026 (US$ Mn)

• Introduction
• Market Share Analysis, By Geography, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, For Geography, 2017–2026
• North America
• Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Disease Indication, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
• U.S.
• Canada
• Europe
• Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Disease Indication, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Disease Indication, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Disease Indication, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Africa
• Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Disease Indication, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
• Central Africa
• South Africa
• North Africa
• Middle East
• Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Disease Indication, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
• GCC
• Israel
• Rest of Middle East

8. Competitive Landscape

• Company Profiles
• Alnylam Pharmaceuticals, Inc.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Ionis Pharmaceuticals, Inc.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Pfizer, Inc.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Eidos Therapeutics, Inc.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Akcea Therapeutics, Inc.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Prothena Corporation Plc.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• GlaxoSmithKline Plc.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• SOM Innovation Biotech, S.L.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies

9. Section

• References
• Research Methodology
• About Us and Sales Contact

*Browse 35 market data tables and 43 figures on "Transthyretin Amyloidosis Treatment Market – Global forecast to 2026”.